newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

AUSTIN, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, announced today that it will hold a conference call on